Uniting China's renowned doctors, championing minimally invasive care, Chinese solutions, shared with the world.
Bringing together senior experts in China's precision minimally invasive cancer treatment field, each with more than 40 years of clinical experience on average. As oncology leaders from China's top three hospitals, they draw on experience from nearly one million surgeries to build an internationally advanced minimally invasive treatment system.
Liao Zhengyin
Professor, M.D., Chief Physician, Grade 1 Expert⁽¹⁾ in the Oncology Center at West China Hospital, Sichuan University⁽²⁾ , Postdoctoral Fellow, Chinese PLA General Hospitals in Beijing, China⁽³⁾, Senior Visiting Scholar at Johns Hopkins Hospital, USA, A leading figure in Multidisciplinary Team (MDT) for complex and difficult tumors in China⁽⁵⁾
Extremely adept at minimally invasive interventional therapies for tumors and treatment of cancer pain, proficient in radioactive seed implantation, ablation, and vascular intervention, with a focus on liver cancer, lung cancer, pancreatic cancer, and bone metastases, and particularly skilled in radioactive seed implantation for refractory cancer pain.
Details
Zhang Jinshan
Professor, M.D., Doctoral Supervisor, Chief Physician, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital⁽¹⁾, Ph.D. of Medicine, Nagasaki University, Japan
He is very involved in treating tumors and blood vessel diseases, focusing on less invasive procedures for issues like liver cancer, cirrhotic portal hypertension, Budd–Chiari syndrome, narrowing and blockage of peripheral blood vessels, both benign and malignant tumors, and benign prostatic hyperplasia. He was among the first in China to perform advanced techniques such as TIPSS and B-ORTO, filling multiple domestic gaps in the field. He also pioneered temporary hepatic vein occlusion combined with hepatic arterial embolization for the treatment of liver cancer, led the development of standardized treatment protocols for liver cancer, and has made significant contributions to the advancement of interventional medicine in China.
Details
Xiao Yueyong
Professor, M.D., Chief Physician, Doctoral Supervisor, Chief Physician at Department of Radiological Diagnosis of Chinese PLA General Hospital⁽¹⁾
Doctor Xiao has an expertise in the individualised minimally-invasive ablation of solid tumours including liver cancer, lung cancer, and pancreatic cancer under the guidance of CT/MRI. Doctor Xiao is proficient in radiofrequency, microwave, cryoablation, and nanoknife ablation technologies, and operates more than thousands of operations annually. Especially, Dr. Xiao has abundant experiences in the precise treatment of the tumours in special anatomical sites such as hepatic hilar region, retroperitoneum, and mediastinal lymph nodes. Further, Dr. Xiao is rather good at combining chemical ablation and seed implantation therapies.
Details
Hu Xiaokun
Professor, M.D., Chief Physician, Doctoral Supervisor, Postdoctoral mentor, Deputy Director of the Interventional Medicine Center of The Affiliated Hospital of Qingdao University, Director of the Qingdao Tumor Interventional Minimally Invasive Technology Innovation Center., Visiting Scholar at Harvard Medical School, USA
Specializes in the treatment of solid tumors, including lung cancer, liver cancer, glioma, and pancreatic cancer, with a particular focus on radioactive iodine-125 seed implantation combined with multimodal ablation techniques such as microwave ablation, radiofrequency ablation, cryoablation, and irreversible electroporation (NanoKnife). Also possesses extensive experience in the management of non-neoplastic diseases, particularly vertebroplasty and minimally invasive treatments for intervertebral disc disorders.
Details
Luo Xiaoping
Associate Professor, M.D., Chief Physician, Master’s Supervisor, Group Leader of the Group of Intervention of Radiological Diagnosis in The Second Affiliated Hospital Of Chongqing Medical University, Member of the Expert Panel for the Medical Quality Control Center
Expertise in precision vascular interventional oncology procedures, (TACE for hepatocellular carcinoma), TIPS, interventional management of Budd–Chiari syndrome, biliary stent placement, and emergency embolization for acute bleeding.
Details
Yi Cheng
Ph.D. in Medicine, Professor, Doctoral Supervisor, Chief Physician, Grade 1 Expert(2) in the Department of Medical Oncology at West China Hospital, Sichuan University(1), PhD in Oncology, Fudan University, China, Postdoctoral Fellow, Faculty of Pharmacy, University of Toronto, Canada, Pioneer in the Integrated Traditional Chinese and Western Medicine
Specializes in chemotherapy for gastric, colorectal, pancreatic, and ovarian cancers, as well as the comprehensive diagnosis and treatment of lung cancer, liver cancer, pancreatic cancer, and bone and soft tissue sarcomas. Skilled in the integrated application of traditional Chinese medicine with chemotherapy, targeted therapy, and immunotherapy, he advocates an integrated traditional Chinese and Western medicine approach to tumor treatment and possesses extensive expertise in anti-angiogenic chemotherapy and the development of traditional Chinese medicine–based antitumor drugs.
Details
Li Zhiping
Professor, M.D., Chief Physician, Doctoral Supervisor, Director of the Discipline of Abdominal tumors,West China Hospital(1), Expert in the Promotion of Precision Radiotherapy Technology in China
Professor Li Zhiping is especially adept at the radiation therapy and chemotherapy of esophageal cancer, gastric cancer, colon cancer, and rectal cancer; the radiation therapy and chemotherapy for the urogenital system tumors of both male and female; the targeted therapy and immunotherapy for the abdominal tumor molecules. Meanwhile, Prof. Li is proficient in the application of new radiation therapy technologies including 3D conformal radiotherapy, intensity-modulated radiotherapy (IMRT), imaging-guided radiation therapy (IGRT), stereotactic radiotherapy (X-knife), image fusion technology, and respiratory gating technology in the treatment of abdominal tumors; meanwhile covering the radiation therapy and chemotherapy of head and neck tumors and breast cancer. Also, Prof. Li has had abundant treatment experience of uncommon and rare cases of tumors.
Details
He Weibing
Associate Chief Physician, Director of the International Campus, Uni-Asia Cancer Hospital, Chengdu
Proficient in NanoKnife and argon-helium tumor ablation techniques, with extensive clinical experience in minimally invasive treatment of liver, lung, kidney, and pelvic tumors. He is especially skilled in ablation therapy for common malignant tumors such as liver, lung, and retroperitoneal tumors, combined with interstitial brachytherapy using iodine-125 seed implantation.
Details
Zhang Junxi
Associate Chief Physician, Vice President of the Zigong Campus of Uni-Asia Hospital (Zigong High-Tech Oncology Hospital) and Director of Ward I
Proficient in the full range of tumor ablation techniques, including chemical ablation, radiofrequency ablation, microwave ablation, argon-helium cryoablation, and NanoKnife ablation. He specializes in intravascular and non-vascular interventional treatment for solid tumors such as liver cancer, lung cancer, and pancreatic cancer.
Details
Wu Chaobo
M.Med., Associate Chief Physician
Proficient in minimally invasive techniques including microwave ablation, cryoablation, radiofrequency ablation, and iodine-125 seed implantation. He has extensive experience in the treatment of various solid tumors, including liver cancer, lung cancer, pancreatic cancer, and breast cancer. He is especially skilled in combining ablation with seed implantation to achieve precise local treatment with minimal trauma and faster recovery.
Details
Bai Xing
M.Med., Associate Chief Physician
Skilled in the essentials of standardized oncology diagnosis and treatment as well as precision therapy. Proficient in flexibly applying advanced minimally invasive techniques including microwave ablation, radiofrequency ablation, argon-helium cryoablation, and interventional infusion embolization. He has also accumulated extensive experience in treating benign and malignant conditions such as uterine fibroids, liver/kidney/ovarian cysts, hemangiomas, and various types of cancer pain.
Details
Guo Donghua
Associate Chief Physician
Dr. Guo is proficient in both vascular and non-vascular minimally invasive interventional techniques. He specializes in transarterial chemoembolization (TACE) and continuous arterial chemotherapy infusion, and is highly skilled in core techniques such as iodine-125 seed implantation, radiofrequency ablation, microwave ablation, and cryoablation. He is also able to perform stent implantation, PTCD, bone cementoplasty, puncture biopsy, and other procedures. Focusing on individualized comprehensive treatment combining interventional therapy, targeted therapy, and immunotherapy for solid tumors such as liver cancer and lung cancer, he has extensive experience in minimally invasive treatment for middle- and late-stage tumors, as well as in managing complications and critical conditions, providing patients with safe, precise, and efficient minimally invasive diagnosis and treatment plans.
Details
Zhou Liang
Associate Chief Physician, Minimally Invasive Interventional Oncology Specialist at Chengdu UNI-ASIA Cancer Hospital
Highly experienced in percutaneous cryoablation, NanoKnife ablation, and iodine seed implantation for various solid tumors, including thyroid tumors, breast tumors, lung tumors, pancreatic tumors, and liver tumors. Skilled in puncture biopsy, molecular targeted therapy, and comprehensive interventional treatment for primary and metastatic tumors. Also experienced in interventional treatment for hepatic hemangioma, drainage for obstructive jaundice, minimally invasive interventional treatment for massive gastrointestinal bleeding and traumatic bleeding, ablation for lower-extremity varicose veins, interventional treatment for arteriovenous thrombosis of the limbs and lower-extremity arteriosclerosis obliterans, as well as interventional treatment for uterine fibroids and adenomyosis.
Details
Luo Jiamin
Associate Chief Physician, Master of Oncology, Chongqing Medical University, Deputy Director of Oncology Ward II, Chengdu Uni-Asia Cancer Hospital
Specializes in the application of immunotherapy combined with local therapy for advanced tumors, as well as chemotherapy, targeted therapy and immunotherapy for solid tumors such as lung cancer, liver cancer and colorectal cancer.
Details
Wu Lizhang
Associate Chief Physician, Director of Ward II, Uni-Asia Cancer Hospital Zigong Campus (Zigong High-tech Oncology Hospital)
Specializes in interventional treatment for malignant tumors of the digestive system, including hepatobiliary, gastrointestinal, and pelvic malignancies. He is dedicated to VTE prevention and treatment as well as interventional management of various tumor-related complications, striving to reduce secondary harm from treatment while patients receive effective anti-tumor therapy. He is also highly experienced in interventional chemotherapy, targeted therapy, immunotherapy, and nutritional support, and is skilled at flexibly combining treatment plans based on each patient’s disease stage and physical condition.
Details
Zhang Wendong
Associate Chief Physician
Proficient in minimally invasive interventional techniques including transarterial chemoembolization (TACE), hepatic arterial infusion chemotherapy (HAIC), microwave ablation, cryoablation, and radioactive iodine-125 seed implantation. Dr. Zhang has accumulated extensive clinical experience in interventional treatment for multiple solid tumors, including liver cancer, lung cancer, pancreatic cancer, colorectal cancer with liver metastasis, gastric cancer, esophageal cancer, nasopharyngeal carcinoma, cholangiocarcinoma, cervical cancer, kidney cancer, bladder cancer, and prostate cancer. He is especially skilled at combining precise vascular interventional embolization with multimodal ablation techniques to realize a synergistic treatment strategy of “local precision targeting + systemic regulation.” He also integrates concepts of traditional Chinese medicine into postoperative rehabilitation, forming an individualized diagnostic and treatment model that combines Chinese and Western medicine, with a commitment to preserving patients’ physiological function and improving quality of life to the greatest extent through minimal trauma.
Details
Hu Xiaona
Intermediate-Level Nurse
Perioperative nursing care for tumor interventional procedures, symptom management for oncology patients, and continuity of care based on international standards.
Details
Cai Mengjie
Master of Medicine, Attending Physician, Physician of Ward I, Chengdu Uni-Asia Cancer Hospital
Specializes in radiotherapy and comprehensive treatment of common malignant tumors including lung cancer, esophageal cancer, breast cancer, nasopharyngeal carcinoma, rectal cancer and liver cancer; full-cycle management for tumor patients before and after radiotherapy, chemotherapy and interventional therapy, including complication management, symptom control and supportive treatment.
Details
Pang Tong
Attending Physician, Physician of Ward I, Chengdu Uni-Asia Cancer Hospital
Specializes in comprehensive diagnosis and treatment of common solid tumors such as lung cancer, gastric cancer, colorectal cancer and liver cancer. Able to formulate precise chemotherapy, targeted therapy and immunotherapy regimens based on individual patient conditions. Skilled in standardized management of tumor complications.
Details
Wang Shuting
Attending Physician, Physician of Ward II, Chengdu Uni-Asia Cancer Hospital
Proficient in multidisciplinary therapies for common clinical malignant tumors including chemotherapy, targeted immunotherapy and interventional therapy. Specializes in comprehensive tumor treatment, and can formulate individualized diagnosis and treatment plans according to the specific conditions of each patient. Committed to improving patients' quality of life and prolonging their survival time.
Details
Li Congying
Attending Physician, Physician of Ward II, Chengdu Uni-Asia Cancer Hospital
Has long worked on frontline clinical tumor diagnosis and treatment. Specializes in comprehensive diagnosis and treatment of common solid tumors including lung cancer, gastric cancer, colorectal cancer and liver cancer, and can formulate precise chemotherapy, targeted therapy and immunotherapy regimens based on individual patient conditions. Skilled in standardized management of nausea, vomiting, myelosuppression and other side effects caused by radiotherapy and chemotherapy. Specializes in standardized diagnosis and treatment of cancer pain, and implements individualized cancer pain management following the three-step analgesic principle.
Details
Chen Yongshao
Attending Physician, Physician of Ward II, Chengdu Uni-Asia Cancer Hospital
Has been engaged in interventional therapy for hemangiomas for many years, with rich experience in the diagnosis and treatment of various types of hemangiomas, vascular malformations and arteriovenous malformations. Has two years of experience in oncology work, specializing in chemotherapy, targeted therapy and immunotherapy for lung cancer and digestive system tumors. Focuses on individualized treatment plans, and pays close attention to patients' quality of life and psychological status during treatment.
Details
Wang Hui
Attending Physician, Physician of Ward II, Chengdu Uni-Asia Cancer Hospital
Engaged in clinical work for many years, accumulated abundant clinical experience in respiratory, digestive and cardiovascular internal medicine. Specializes in standardized diagnosis and treatment of common and chronic internal diseases. Able to independently and standardly complete diagnosis, treatment and health guidance for various internal diseases. Can formulate individualized and comprehensive tumor diagnosis, treatment and symptomatic supportive regimens based on patients' underlying internal diseases. Possesses rich practical experience in managing radiotherapy and chemotherapy adverse reactions, cancer pain control, nutritional support, physical and mental care, and full-cycle chronic disease management for tumor patients. Provides safer, standardized and high-quality medical services for tumor patients complicated with multiple underlying diseases.
Details
Huang Wenhui
Attending Physician, Physician of Ward II, Chengdu Uni-Asia Cancer Hospital
Specializes in individualized comprehensive diagnosis and treatment of malignant tumors, including comprehensive management of common solid tumors such as lung cancer, gastric cancer, colorectal cancer, liver cancer, esophageal cancer, breast cancer, gynecological tumors, head and neck tumors and systemic metastatic carcinoma. Has years of frontline clinical experience in medical oncology, prioritizes appropriate treatment modalities based on each patient’s tumor condition. Clinically proficient in chemotherapy, targeted therapy, immunotherapy and radiotherapy. Skilled in standardized management of adverse reactions arising from radiotherapy, chemotherapy, immunotherapy and targeted therapy with full-cycle patient care. Attaches great importance to full-disease-cycle management, and adopts integrated traditional Chinese and Western medicine combined with tumor nutrition for adjuvant conditioning.
Details
Cheng Long
Attending Physician, Physician of Ward I, Chengdu Uni-Asia Cancer Hospital
Performs routine interventional examinations and interventional surgeries in clinical practice. Specializes in peripheral vascular and non-vascular interventional therapy (tumor and non-tumor related), including gastrointestinal nutrition tube placement, intestinal obstruction catheterization, PTCD, various puncture biopsies, TACE, bronchial artery embolization, left gastric artery embolization, splenic artery embolization, inferior vena cava filter placement and retrieval, cerebral angiography, etc.
Details
Huang Xin
Attending Physician, Physician of Ward I, Chengdu Uni-Asia Cancer Hospital
Proficient in chemotherapy, targeted therapy, immunotherapy and other treatments for malignant tumors, and has accumulated rich experience especially in the internal medicine treatment of lung cancer, liver cancer, digestive tract tumors and other diseases.
Details
Li Yaling
Attending Physician, Physician of Ward I, Chengdu Uni-Asia Cancer Hospital
Focuses on the diagnosis and treatment of multi-system internal diseases, with solid experience in treating various respiratory, digestive, endocrine and other disorders; specializes in full-cycle comprehensive management and personalized care for advanced tumors.
Details
Zhou Lingli
Attending Physician, Physician of Ward I, Chengdu Uni-Asia Cancer Hospital
Possesses rich clinical experience in the diagnosis, treatment, rehabilitation and prevention of common and multiple tumors, as well as relevant experience in diagnosing and treating common, frequently-occurring and difficult cases in general internal medicine.
Details
Teng Haoqi
Master of Medicine, Associate Chief Physician, Physician of Ward I, Chengdu Uni-Asia Cancer Hospital
Specializes in minimally invasive interventional therapy and integrated traditional Chinese and Western medicine treatment for various solid malignant tumors including lung cancer, liver cancer, colorectal cancer, pancreatic cancer, gastric cancer, breast cancer, cervical cancer, ovarian cancer, prostate cancer, secondary malignant bone tumors all over the body, benign and malignant thyroid tumors. Also engages in diagnosis and treatment of benign tumors such as hemangiomas and vascular malformations. Skilled in controlling malignant complications such as malignant pleural and peritoneal effusion. Specializes in minimally invasive interventional diagnosis and treatment of uterine fibroids and ovarian cysts.
Details
Treatment Technologies
Providing targeted, world-class precision treatment solutions for patients worldwide.
More Treatments
Patient stories
At UNI-ASIA Cancer Hospital, every journey in search of care is marked by courage and hope, and every story bears witness to doctors and patients working together to overcome disease.
More Cases